Leading the "AI + Protein" Track, PharmaInnovation Collaborates with Nobel Prize Team to Develop Industry Standards for Protein Design_Company News_News Center_PharmaInnovation Medical Technology (Shanghai) Co., Ltd.

EN CN



Home News Company News Leading the "AI + Protein" track, SmartPharm is collaborating with a Nobel Prize-winning team to develop industry standards for protein design.

Leading the "AI + Protein" track, SmartPharm is collaborating with a Nobel Prize-winning team to develop industry standards for protein design.

Company NewsFebruary 27, 2025

return

[A Breakthrough in AI + Protein Design!] AI-Powered Biotech has partnered with a Nobel Prize-winning team to develop industry standards for protein design, leading the "AI + Protein" race! This collaboration will drive technological innovation in the biopharmaceutical field and accelerate new drug development. Click the link to learn more about this cross-disciplinary collision of science and life sciences!

Artery Network: In 2020, with the emergence of AlphaFold, the "AI + Biology" field ushered in a period of explosive growth. Especially in the medical field, artificial intelligence has become a huge application scenario, with significant cost reduction and efficiency improvement effects across the entire industry chain, bringing revolutionary changes to the industry. By 2025, the emergence of DeepSeek in the artificial intelligence industry has caused a huge stir, and the ripples have spread to the AI pharmaceutical industry.

Previous article: The world's first AI-designed long-acting GLP-1 weight loss drug is about to be launched by AI-driven PharmPion. Next article: AI-powered pharmaceutical innovation wins Shanghai Jiao Tong University's "Future Star" award! AI+medical innovation receives further authoritative recognition. Return to list